Merck Sharp & Dohme Romania secures contract for Antineoplastic and immunomodulating agents - framework agreement for the supply of medicines from the group; "antineoplastic and immunomodulatory - Pembrolizumab conc pt sol perf 25mg/ml - "

Romania, Oct. 7 -- Romania based Merck Sharp & Dohme Romania has secured contract from Operator SEAP for Antineoplastic and immunomodulating agents - framework agreement for the supply of medicines from the group; "antineoplastic and immunomodulatory - Pembrolizumab conc pt sol perf 25mg/ml - ". The value of the contract is 646794.6 RON.

Published by HT Digital Content Services with permission from Pivotal Sources....